Clinical Trials Directory

Trials / Completed

CompletedNCT01755026

Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery

Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery Receiving Two Differing Doses of Pre-operative Cefazolin.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Michael Stitely · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients undergoing Cesarean delivery (C-Section) with a body mass index of 35 or greater (this BMI number is in the obese range) will be given either 2 grams or 4 grams of an antibiotic before surgery. The antibiotic is intended to prevent infection from the surgery.It is unknown what the best dose for large women is for the usual medicine used for this purpose (an antibiotic medicine called cefazolin).Samples of the tissue just under the skin will be biopsied at the time the incision is made and at the time the cut is stitched or stapled closed. A sample of the muscle of the womb will be taken as the womb is stitched closed after the delivery. Blood tests will be done at the start and end of surgery to test the antibiotic level. A blood sample will be taken from the umbilical cord after the baby has been delivered and the umbilical cord has been cut. The umbilical cord blood sample will be tested for the antibiotic level.These tests will be used to find out if the usual dose of medicine is enough or if more medicine is needed to prevent infection in large women undergoing c-sections.

Conditions

Interventions

TypeNameDescription
DRUGcefazolin2 gram dose for pre-operative prophylaxis
DRUGcefazolin4 gram dose for pre-operative prophylaxis

Timeline

Start date
2010-11-01
Primary completion
2011-07-01
Completion
2012-11-01
First posted
2012-12-21
Last updated
2013-08-21
Results posted
2013-08-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01755026. Inclusion in this directory is not an endorsement.

Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery (NCT01755026) · Clinical Trials Directory